Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - lactulose - oral solution - 3.335 g/5ml - osmotically acting laxatives - osmotically acting laxatives - constipation hepatic encephalopathy (he): treatment and prevention of hepatic coma or precoma

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - dydrogesterone - film coated tablet - 10 milligram - pregnadien derivatives - urinary system and sex hormones - in the management of conditions associated with progesterone insufficiency: dysmenorrhoea, endometriosis, infertility, irregular menstrual cycles and pre-menstrual syndrome. the drug may be used with an estrogen in the management of dysfunctional bleeding or secondary amenorrhoea, or in association with estrogen in hormone replacement therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol - film coated tablet - 2 milligram - natural and semisynthetic estrogens, plain - natural and semisynthetic oestrogens, plain - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 6 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol hemihydrate - film coated tablet - 1 milligram - natural and semisynthetic estrogens, plain - natural and semisynthetic oestrogens, plain - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 6 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol, dydrogesterone - film coated tablet - 1mg/5mg milligram - progestogens and estrogens, fixed combinations - : genito urinary system and sex hormones, progestogens and oestrogens, fixed combinations - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 12 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ireland limited - verapamil hydrochloride - film-coated tablets - 80mg - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - prophylaxis and/or treatment of:-
angina pectoris, including prinzmetal’s angina (coronary spasm, vasospastic angina).
supraventricular tachycardias such as paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with rapid ventricular response (except in wpw syndrome, see “contraindications”).
mild to moderate essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - fenofibrate - capsules hard - 67 milligram - fibrates - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - fenofibrate. - capsule, hard. - 200mg - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - fenofibrate - film coated tablet - 145 milligram - fibrates - serum lipid reducing agents / cholesterol and triglycerides reducers / fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following:
treatment of severe hypertriglyceridaemia with or without low hdl cholesterol.
mixed hyperlipidaemia when a statin is contraindicated or not tolerated.
mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - betahistine hydrochloride - tablets - 8 milligram - antivertigo preparations - anti-vertigo preparations - vertigo, tinnitus and hearing loss associated with ménière's syndrome